Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
B-cell Immunity to Influenza (Year 5)
NCT03020537Phase 4Completed
- Sponsor
- Stanford University
- Start
- Oct 2013
- Primary completion
- Dec 2013
- Modality
- Vaccines & Immunotherapeutics
01
Overview
A Phase 4 trial of Fluzone Trivalent in influenza, sponsored by Stanford University. Started Oct 2013; status: completed.
02
Drugs
Fluzone Trivalent
03
Conditions
influenza
Beyond the preview
Go deeper on NCT03020537.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03020537.